The DETECT study: Personalised treatment in advanced breast cancer based on circulating tumour cells - European Medical Journal

Continue

The DETECT study: Personalised treatment in advanced breast cancer based on circulating tumour cells

Oncology

At the European Cancer Congress (ECC) 2015, Wolfgang Janni, MD, PhD University Hospital Ulm, Ulm, discusses the interim analysis of the DETECT study, which was designed to evaluate the prognostic and predictive value of HER2-status of circulating tumour cells in patients with metastatic breast cancer.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.